Use of Transcarotid IMPELLA 2.5 Axial-Flow Pump Device for Left Ventricle Unloading During VA-ECMO Support in Pediatric Acute Heart Failure.
Gianluigi PerriMatteo TrezziRoberto FormigariRachele AdorisioSergio FilippelliGianluca BrancaccioLorenzo GallettiAntonio AmodeoPublished in: World journal for pediatric & congenital heart surgery (2022)
An alternative strategy for left ventricular (LV) venting during short-term mechanical circulatory support is use of Impella axial-flow pump. We present our transcarotid Impella 2.5 implantation technique using a polytetrafluoroethylene graft, in two children with acute heart failure treated primarily with venoarterial ECMO. The venoarterial extracorporeal membrane oxygenator and Impella support were maintained for 5 and 17 days, respectively. Transcarotid Impella implantation might be an alternative and feasible option in pediatrics patients affected by severe LV failure, as a bridge to decision or bridge to candidacy. Potentially, the Impella 2.5 device provides less invasive support for children with heart failure.
Keyphrases
- extracorporeal membrane oxygenation
- acute heart failure
- heart failure
- acute respiratory distress syndrome
- left ventricular
- respiratory failure
- end stage renal disease
- young adults
- chronic kidney disease
- ejection fraction
- cardiac resynchronization therapy
- left ventricular assist device
- acute myocardial infarction
- coronary artery
- acute coronary syndrome
- pulmonary artery
- hypertrophic cardiomyopathy
- decision making
- percutaneous coronary intervention